Literature DB >> 8411372

Replication of a macrophage-tropic strain of human immunodeficiency virus type 1 (HIV-1) in a hybrid cell line, CEMx174, suggests that cellular accessory molecules are required for HIV-1 entry.

K A Stefano1, R Collman, D Kolson, J Hoxie, N Nathanson, F Gonzalez-Scarano.   

Abstract

To investigate the mechanism underlying one aspect of the cellular tropism of human immunodeficiency virus type 1 (HIV-1), we used a macrophage-tropic isolate, 89.6, and screened its ability to infect a number of continuous cell lines. HIV-1 (89.6) was able to replicate robustly in a T-cell/B-cell hybrid line, CEMx174, while it replicated modestly or not at all in either of its parents, one of which is the CD4-positive line CEM.3. Analysis by transfection of a molecular clone, a virus uptake assay, and polymerase chain reaction all provided strong evidence that the block to HIV-1(89.6) replication in the CEM.3 line lies at the level of cellular entry. These results were complemented by preparing a CD4-expressing derivative of the B-cell parent, 721.174, and demonstrating that it is permissive for productive HIV-1(89.6) replication. Given these experimental findings, we speculate that there exist cellular accessory factors which facilitate virus entry and infection in CD4-positive cells. Furthermore, these cellular accessory factors may be quite virus strain specific, since not all macrophage-tropic strains of HIV-1 were able to replicate in the CEMx174 hybrid cell line. This experimental model provides a system for the identification of one or more of these putative cellular accessory factors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8411372      PMCID: PMC238110     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.

Authors:  G E FOLEY; H LAZARUS; S FARBER; B G UZMAN; B A BOONE; R E MCCARTHY
Journal:  Cancer       Date:  1965-04       Impact factor: 6.860

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency.

Authors:  T Folks; D M Powell; M M Lightfoote; S Benn; M A Martin; A S Fauci
Journal:  Science       Date:  1986-02-07       Impact factor: 47.728

4.  Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

Authors:  R D Salter; D N Howell; P Cresswell
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

Review 5.  Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens.

Authors:  R DeMars; C C Chang; S Shaw; P J Reitnauer; P M Sondel
Journal:  Hum Immunol       Date:  1984-10       Impact factor: 2.850

6.  The nucleotide sequence of the human beta-globin gene.

Authors:  R M Lawn; A Efstratiadis; C O'Connell; T Maniatis
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

7.  Human T-B lymphoblast hybrids express HLA-DR specificities not expressed by either parent.

Authors:  D N Howell; A E Berger; P Cresswell
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

8.  Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism.

Authors:  N E Sharpless; W A O'Brien; E Verdin; C V Kufta; I S Chen; M Dubois-Dalcq
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types.

Authors:  R Collman; N F Hassan; R Walker; B Godfrey; J Cutilli; J C Hastings; H Friedman; S D Douglas; N Nathanson
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Mechanisms of resistance to HIV infection.

Authors:  W A Paxton; R A Koup
Journal:  Springer Semin Immunopathol       Date:  1997

2.  A monoclonal antibody (12G5) directed against CXCR-4 inhibits infection with the dual-tropic human immunodeficiency virus type 1 isolate HIV-1(89.6) but not the T-tropic isolate HIV-1(HxB).

Authors:  J M Strizki; J D Turner; R G Collman; J Hoxie; F González-Scarano
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer.

Authors:  V Litwin; K A Nagashima; A M Ryder; C H Chang; J M Carver; W C Olson; M Alizon; K W Hasel; P J Maddon; G P Allaway
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Lentivirus vectors using human and simian immunodeficiency virus elements.

Authors:  S M White; M Renda; N Y Nam; E Klimatcheva; Y Zhu; J Fisk; M Halterman; B J Rimel; H Federoff; S Pandya; J D Rosenblatt; V Planelles
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes.

Authors:  G Herbein; C Van Lint; J L Lovett; E Verdin
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus.

Authors:  C C LaBranche; M M Sauter; B S Haggarty; P J Vance; J Romano; T K Hart; P J Bugelski; J A Hoxie
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages.

Authors:  N Yahi; J Fantini; K Mabrouk; C Tamalet; P de Micco; J van Rietschoten; H Rochat; J M Sabatier
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Human plasma enhances the infectivity of primary human immunodeficiency virus type 1 isolates in peripheral blood mononuclear cells and monocyte-derived macrophages.

Authors:  S C Wu; J L Spouge; S R Conley; W P Tsai; M J Merges; P L Nara
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera.

Authors:  T Wrin; T P Loh; J C Vennari; H Schuitemaker; J H Nunberg
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

10.  Infection of SK-N-MC cells, a CD4-negative neuroblastoma cell line, with primary human immunodeficiency virus type 1 isolates.

Authors:  J M Harouse; F González-Scarano
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.